about
Immunotherapy for head and neck squamous cell carcinomaThe promise of immunotherapy in head and neck squamous cell carcinomaThe emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsEarly detection and personalized treatment in oral cancer: the impact of omics approachesTreatment of Elderly Patients with Squamous Cell Carcinoma of the Head and NeckAn update on larynx cancerhrHPV E5 oncoprotein: immune evasion and related immunotherapies.Immunotherapy in head and neck cancer: aiming at EXTREME precision.Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccinationCD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavityKv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC.Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.Head and Neck Carcinoma Immunotherapy: Facts and Hopes.STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.Immunotherapy for head and neck cancer: the future of treatment?Adoptive T-Cell Therapy for Solid Tumors.MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes.Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies.Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.Treatment of head and neck cancer in the elderly.Cancer Immunology and HPV.T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.Human papillomavirus related oropharyngeal cancer.Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.Pembrolizumab: the value of PDL1 biomarker in head and neck cancer.T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer.Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.Head and neck cancer: improving outcomes with a multidisciplinary approach.Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy.Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma.Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
P2860
Q26739850-67722630-D6AB-4104-9C45-6A9845964184Q26744433-A026C2AE-8BA8-489D-BEC3-9D64A387E18DQ26747516-7A87FC4C-6E09-45D3-9330-5F52395EF952Q28073927-6054927B-D65B-4397-AE75-4925E3753FBCQ28076894-F1A1BFAB-FAE4-4213-9174-2F9E26D4FCD0Q28079132-E74D0206-B190-41E5-B7FE-749C7E433676Q33730462-123E0CE8-3EB0-4D6C-B0AC-B0F759169A74Q33756244-10599A47-EAF8-4319-BD75-6B07DE624BCBQ35933820-E625612B-C80A-4A28-9FED-98AD2F3BBB3EQ36489891-8F8E4236-5BC5-41E4-A044-AB382AD7837FQ37022094-0299BE16-783C-493E-8E44-F1C2674AF905Q37559965-13306605-F00C-47E7-9CF9-1162960E026EQ37675926-B457B5DF-2F86-4871-AF0B-0F537D34FE60Q37684668-B6225009-E01F-4E81-A270-C0A720B93192Q38650710-61A50787-9B4E-4DC2-A147-A85C9FF460C9Q38700564-D5285A8C-A614-47FC-A79F-DCC3185D174EQ38736238-A3FADE38-BEC8-42FA-9792-FD74487D8996Q38754498-DB3286F0-A4BC-4A8B-A58E-8E72291C5EC9Q38845661-D585BB64-7701-4DD6-9C1A-C88FEF102C6EQ38851114-6DAC4515-D410-426E-A891-76EEA71CB7E8Q38855031-87CB5FE3-B482-477C-97FD-1D1A3A81B06CQ38892486-4C1E3D27-170E-41C9-B1CB-5A4553F39DE5Q38958367-D500636D-76E2-489E-9B55-32C8672A360EQ38971582-BBBA6318-7BD4-448F-89AF-6EDE06842243Q39124682-7154F344-DB75-41AB-93B7-882978BF75C4Q39190801-115A7099-2DB9-4866-B3D3-D2B8F602E8EEQ39308337-53259A62-E167-4DC5-B6A2-810697F6AA21Q39626142-C02135A7-C840-4692-BB8F-7CABA27E3599Q39627356-CCD2EB50-EAAB-419A-9A37-9913CF1EEFABQ40152615-A0F6AF2B-86EE-42E7-8AAB-9A3298AD5EF8Q40446457-87FD7482-E87A-4C77-A534-D7D7E9D15228Q40448724-30BEF490-EB0A-48A4-8B53-61E82620C596Q40654130-D38C2010-18A3-4604-889F-C7923FBAF14FQ41127889-3C69EA69-FF31-45BC-9B78-E9B4F8F815F5Q41206627-E21718FA-5775-492F-879E-02E4E3D5E229Q41522410-A42E5EED-3E58-4780-92F3-CD48973FF30EQ41633683-A9A0FDF6-7606-41DE-86E8-81620A85D585Q41924893-56095533-748E-4AE9-9B10-B7523DC95EC6Q41925180-72B1DFD6-D82F-4734-A298-4ACF44FF5F8AQ41934319-FFDCF7FA-0831-43AC-A121-8190ABF52EC5
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunology and Immunotherapy of Head and Neck Cancer
@ast
Immunology and Immunotherapy of Head and Neck Cancer
@en
type
label
Immunology and Immunotherapy of Head and Neck Cancer
@ast
Immunology and Immunotherapy of Head and Neck Cancer
@en
prefLabel
Immunology and Immunotherapy of Head and Neck Cancer
@ast
Immunology and Immunotherapy of Head and Neck Cancer
@en
P2860
P356
P1476
Immunology and Immunotherapy of Head and Neck Cancer
@en
P2093
Robert L Ferris
P2860
P304
P356
10.1200/JCO.2015.61.1509
P407
P577
2015-09-08T00:00:00Z